Hyperfine (HYPR) Return on Capital Employed (2021 - 2026)
Hyperfine (HYPR) reported Return on Capital Employed of 72.91% for Q1 2026, up 1736.0% on a YoY basis from 3.97% in Q1 2025, and up 27.93% quarter-over-quarter from 101.17% in Q4 2025.
Hyperfine (HYPR) Return on Capital Employed (2021 - 2026) Analysis & Trends
Hyperfine has reported Return on Capital Employed for 6 years, with the latest figure at 72.91% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 1736.0% year-over-year to 72.91%; the trailing twelve-month figure through Mar 2026 stood at 72.91% (up 1736.0% YoY), and the FY2025 full-year result was 81.78%, down 1804.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 72.91%, up from 101.17% in the prior quarter.
- The five-year high for Return on Capital Employed was 45.1% in Q1 2022, with the low at 121.01% in Q3 2025.
- Historically, Return on Capital Employed has averaged 69.13% across 5 years, with a median of 60.56% in 2022.
- Annual changes were most pronounced in 2025 — Return on Capital Employed slumped 5108 bps — and 2026, when it soared 1736 bps.
- Hyperfine's Return on Capital Employed stood at 55.8% in 2022, then grew by 4 bps to 53.54% in 2023, then tumbled by 46 bps to 78.0% in 2024, then dropped by 30 bps to 101.17% in 2025, then gained by 28 bps to 72.91% in 2026.
- The last three Return on Capital Employed figures came in at 72.91% (Q1 2026), 101.17% (Q4 2025), and 121.01% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Hyperfine | 155.82 Mn | 114.55 Mn | 1.98 Mn | -72.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -72.91% |
| Dec 31, 2025 | -101.17% |
| Sep 30, 2025 | -121.01% |
| Jun 30, 2025 | -102.20% |
| Mar 31, 2025 | -90.27% |
| Dec 31, 2024 | -78.00% |
| Sep 30, 2024 | -69.94% |
| Jun 30, 2024 | -62.13% |
| Mar 31, 2024 | -56.42% |
| Dec 31, 2023 | -53.54% |
| Sep 30, 2023 | -50.30% |
| Jun 30, 2023 | -47.24% |
| Mar 31, 2023 | -52.58% |
| Dec 31, 2022 | -55.80% |
| Sep 30, 2022 | -60.56% |
| Jun 30, 2022 | -55.97% |
| Mar 31, 2022 | -45.10% |
| Dec 31, 2021 | -34.24% |